These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7927273)

  • 21. Precipitating factors of hepatic encephalopathy in patients with chronic liver disease at Civil Hospital Karachi.
    Rohra DK; Jaipal ; Khowaja AA; Mahmood K; Ahuja KL
    J Coll Physicians Surg Pak; 2008 Feb; 18(2):130-1. PubMed ID: 18454907
    [No Abstract]   [Full Text] [Related]  

  • 22. Haemodynamic assessment.
    Lebrec D
    Baillieres Clin Gastroenterol; 1995 Dec; 9(4):759-69. PubMed ID: 8903804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas.
    Krowka MJ
    Hepatology; 1997 May; 25(5):1282-4. PubMed ID: 9141454
    [No Abstract]   [Full Text] [Related]  

  • 24. The visual evoked potential in clinical hepatic encephalopathy in acute and chronic liver disease.
    Levy LJ; Bolton RP; Losowsky MS
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():66-73. PubMed ID: 2083938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Portal hypertension in the cardiac patient].
    Jiménez-Romo F
    Arch Inst Cardiol Mex; 1972; 42(2):235-8. PubMed ID: 5063798
    [No Abstract]   [Full Text] [Related]  

  • 26. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatic blood flow, portal hypertension and liver failure in patients with alcoholic cirrhosis (author's transl)].
    Lebrec D; Sicot C; Benhamou JP
    Arch Fr Mal App Dig; 1973 Sep; 62(6):465-71. PubMed ID: 4779228
    [No Abstract]   [Full Text] [Related]  

  • 28. Pathophysiology of portal hypertension.
    Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC
    Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of extrahepatic vasodilation in portal hypertension.
    Hennenberg M; Trebicka J; Sauerbruch T; Heller J
    Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathomorphology and histochemistry of spontaneous and experimental encephalopathy of hepatic origin].
    Mossakowski MJ
    Neuropatol Pol; 1966; 4(2):231-304. PubMed ID: 5928073
    [No Abstract]   [Full Text] [Related]  

  • 31. Splanchnic and systemic vasodilatation: the patient.
    Tsai MH
    J Clin Gastroenterol; 2007; 41 Suppl 3():S266-71. PubMed ID: 17975476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology of liver circulation with an overview of medical and invasive treatments.
    Bombardieri G; Conti LR
    Rays; 1997; 22(2):196-210. PubMed ID: 9351328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic hepatic encephalopathy in cirrhotic patients and spontaneous portacaval anastomosis. Portal angiographic and manometric study].
    Bauret P; Mirouze D; Bories P; Mourrut C; Bruel JM; Michel H
    Gastroenterol Clin Biol; 1989; 13(2):132-5. PubMed ID: 2707522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and physiological abnormalities in hepatic function.
    Grand RJ; Ulshen MH
    Pediatr Clin North Am; 1975 Nov; 22(4):897-928. PubMed ID: 1105366
    [No Abstract]   [Full Text] [Related]  

  • 35. The biochemistry of hepatic failure.
    Riddell AG
    Br J Anaesth; 1969 Mar; 41(3):257-63. PubMed ID: 5776670
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sequelae of portosystemic shunt operations].
    Berchtold R; Paumgartner G
    Z Gastroenterol Verh; 1982 Apr; 17():59-67. PubMed ID: 6191460
    [No Abstract]   [Full Text] [Related]  

  • 37. Portal hypertension in sarcoid liver disease with hypomelanotic skin involvement.
    Mehrotra S; Krishnan PV; Reddy BS; Arora A; Anuradha S; Kar P
    Trop Gastroenterol; 2004; 25(4):168-9. PubMed ID: 15912975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of hepatic encephalopathy in portacaval shunts and mesenterico-caval bypass with the jugular vein].
    Thau A; Bucci L; Ziparo V; Schillaci A
    Minerva Chir; 1975 Apr; 30(8):449-53. PubMed ID: 1128785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathogenesis of portal hypertension].
    Montaño-Loza A; Meza-Junco J
    Rev Invest Clin; 2005; 57(4):596-607. PubMed ID: 16315644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased intracranial pressure and hepatic encephalopathy in chronic liver disease.
    Crippin JS; Gross JB; Lindor KD
    Am J Gastroenterol; 1992 Jul; 87(7):879-82. PubMed ID: 1615943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.